What is pre-COPD and do we know how to treat it?

Expert review of respiratory medicine Pub Date : 2024-06-01 Epub Date: 2024-07-03 DOI:10.1080/17476348.2024.2375418
Davor Plavec, Žarko Vrbica
{"title":"What is pre-COPD and do we know how to treat it?","authors":"Davor Plavec, Žarko Vrbica","doi":"10.1080/17476348.2024.2375418","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Chronic Obstructive Pulmonary Disease (COPD) is one of the leading causes of morbidity and mortality worldwide. The lung damage in COPD is associated with an enhanced chronic inflammatory response in the airways and lung tissue to harmful particles or gases. Early detection and treatment of COPD can help manage symptoms and slow the progression of the disease.</p><p><strong>Areas covered: </strong>Status of knowledge regarding early diagnosis, definition of pre-COPD, possible new tools for early diagnosis, possibilities of early treatment, and the results of studies in this population are discussed. Literature search (2014-2024) was done in PubMed, EMBASE, and WoS databases using the keywords COPD, early diagnosis, treatment, smoking, prevention; with additional search of literature in found articles.</p><p><strong>Expert opinion: </strong>No early case-finding programs have been proposed or validated, so we still have many patients diagnosed in the late stage of the disease. Clinically manifest COPD is characterized as typically progressive and irreversible with current therapeutic options. If we aim to reduce the mortality and morbidity from COPD we should target these steps: Prevention; Early diagnosis; Form registries of persons at risk for COPD development; Diagnose preclinical COPD; and discover new preventive therapeutic interventions.</p>","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert review of respiratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17476348.2024.2375418","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/3 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Chronic Obstructive Pulmonary Disease (COPD) is one of the leading causes of morbidity and mortality worldwide. The lung damage in COPD is associated with an enhanced chronic inflammatory response in the airways and lung tissue to harmful particles or gases. Early detection and treatment of COPD can help manage symptoms and slow the progression of the disease.

Areas covered: Status of knowledge regarding early diagnosis, definition of pre-COPD, possible new tools for early diagnosis, possibilities of early treatment, and the results of studies in this population are discussed. Literature search (2014-2024) was done in PubMed, EMBASE, and WoS databases using the keywords COPD, early diagnosis, treatment, smoking, prevention; with additional search of literature in found articles.

Expert opinion: No early case-finding programs have been proposed or validated, so we still have many patients diagnosed in the late stage of the disease. Clinically manifest COPD is characterized as typically progressive and irreversible with current therapeutic options. If we aim to reduce the mortality and morbidity from COPD we should target these steps: Prevention; Early diagnosis; Form registries of persons at risk for COPD development; Diagnose preclinical COPD; and discover new preventive therapeutic interventions.

什么是慢性阻塞性肺病前期,我们知道如何治疗吗?
导言:慢性阻塞性肺病(COPD)是全球发病和死亡的主要原因之一。慢性阻塞性肺病的肺损伤与气道和肺组织对有害颗粒或气体的慢性炎症反应增强有关。早期发现和治疗慢性阻塞性肺病有助于控制症状和减缓病情发展:讨论了有关早期诊断的知识现状、慢性阻塞性肺病前期的定义、早期诊断的可能新工具、早期治疗的可能性以及针对此类人群的研究结果。使用 COPD、早期诊断、治疗、吸烟、预防等关键词在 PubMed、EMBASE 和 WoS 数据库中进行了文献检索(2014-2024 年),并对已找到的文章进行了额外的文献检索:专家意见:目前尚未提出或验证早期病例发现计划,因此仍有许多患者在疾病晚期才被确诊。临床表现为慢性阻塞性肺病的特点是典型的进展性和不可逆转性,而目前的治疗方案是不可逆的。如果我们要降低慢性阻塞性肺病的死亡率和发病率,就应该采取以下措施:预防;早期诊断;建立慢性阻塞性肺病高危人群登记册;诊断临床前慢性阻塞性肺病;发现新的预防性治疗干预措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信